Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format LAS VEGAS, Jan. 11, 2021 (GLOBE NEWSWIRE) — CES – Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Bioheart, a personal heart monitor. Designed for individuals diagnosed with or at risk for cardiovascular disease, Bioheart continuously […]
Rhythm
OMRON Healthcare Continues to Transform the Heart Health Marketplace with New Remote Patient Monitoring Service & Digital Health Tools at CES 2021
Global heart health leader introduces VitalSight™, its first remote patient monitoring service, and previews a new app that will increase the capabilities of every OMRON connected blood pressure monitor LAKE FOREST, Ill., Jan. 11, 2021 /PRNewswire/ — OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal heart health […]
Ultromics receives FDA Clearance for a first-of-kind solution in Echocardiography to help clinicians diagnose disease
EchoGo Pro is an AI service for automated identification of coronary artery disease – FDA gives 510(K) clearance for EchoGo Pro, expanding the use of Ultromics’ EchoGo service to support clinicians diagnosing coronary artery disease – Every year in the U.S. over 800,000 people die from heart disease – accounting […]
ZOLL Medical’s Advanced Defibrillators Win Five-Star World of Safety & Health Asia Award 2020
ZOLL AED 3 and ZOLL AED 3 BLS Recognized by World of Safety & Health Asia for Their Innovative Technology for All Rescuers CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that its ZOLL AED 3® and ZOLL AED 3 BLS automated […]
BioSerenity Announces FDA Clearance for Electroencephalography (EEG) Wearable Device System
Neuronaute® EEG System and IceCap® bring Comprehensive Remote Electroencephalography Monitoring Services to People Living with Neurological Disorders. PARIS and ATLANTA, Jan. 5, 2021 /PRNewswire/ — BioSerenity, Inc., a leading global provider of remote diagnostic solutions in the areas of Neurology, Cardiology and Sleep Disorders announced today it received U.S. Food and Drug Administration (FDA) 510(k) […]
Biotricity Submitted 510(k) U.S. FDA Filing for Biotres
Biotres is a compact and discreet 3 channel holter solution REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA), on December 31 2020, for Biotres. The company expects this process to take […]
AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy
Expansion includes adolescent patients, as young as 12 years of age, who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall. MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that […]
BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
NeuroClear is set to commence experiments aimed at developing therapies for autonomic nervous system disease Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover […]
3M™ Littmann® Stethoscopes and eMurmur® Partner to Launch New Educational Apps
Redefining what’s possible in healthcare ST. PAUL, Minn. and OTTAWA, Canada, Dec. 18, 2020 /PRNewswire/ — Becoming skilled in auscultation requires practice and repeated exposure to real patient heart and lung sounds. In response to that need, 3M™ Littmann® Stethoscopes has joined forces with eMurmur® to release two new branded apps – one to support students and […]
FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval
– Large, Randomized Controlled ADVENT Trial Designed to Establish New Gold Standard for AF Ablation – MENLO PARK, Calif., Dec. 17, 2020 /PRNewswire/ – FARAPULSE Inc. (“FARAPULSE” or “the Company”) today announced the U.S. Food and Drug Administration (FDA) conditionally approved the Company’s Investigational Device Exemption (IDE) application to initiate its U.S. pivotal ADVENT […]



